Exposure to indoor mould and children's respiratory health in the PATY study

T Antova1, S Pattenden, B Brunekreef

  • 1Environmental Health Unit, NCPHP, Sofia, Bulgaria.

Insights

Living in a damp home with visible mould is linked to poorer respiratory health in children. This study analyzed data from over 58,000 children, confirming mould as a significant risk factor for cough and other respiratory issues.

Area of Science:

  • Environmental health
  • Pediatric respiratory medicine
  • Epidemiology

Background:

  • Damp and mouldy homes are suspected to negatively impact children's respiratory health.
  • Public perception may underestimate mould as a significant health risk.
  • The study utilizes data from the Pollution and the Young (PATY) study, pooling information from 12 cross-sectional studies.

Purpose of the Study:

  • To assess the association between indoor mould exposure and a range of respiratory and allergic symptoms in children.
  • To investigate the impact of air quality on pediatric respiratory disorders.
  • To quantify the risk of respiratory symptoms associated with visible household mould.

Main Methods:

  • Data from over 58,000 children aged 6-12 years were pooled from 12 cross-sectional studies across Russia, North America, and Europe.
  • Logistic regression models were employed to estimate associations between reported household mould and eight respiratory/allergic symptoms, controlling for individual and area-level factors.
  • Meta-analysis was used to estimate mean effects and assess heterogeneity between study-specific results.

Main Results:

  • Visible mould was reported by 13.9% in Russia to 39.1% in North America.
  • Consistent positive associations were found between mould exposure and children's respiratory symptoms, including nocturnal cough (OR 1.30) and morning cough (OR 1.50).
  • Stronger effects of mould were observed in more crowded households for asthma and sensitivity to inhaled allergens, but no consistent interactions with age, sex, or parental smoking were detected.

Conclusions:

  • Indoor mould exposure is consistently linked to adverse respiratory health outcomes in children.
  • The findings highlight the importance of addressing mould in homes to protect pediatric respiratory health.
  • This large-scale international study provides robust evidence on the detrimental effects of indoor mould on children's well-being.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...